# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-010427
Filing Date
2024-03-19
Accepted
2024-03-19 08:30:54
Documents
70
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 2408085
2 |  | ex10-16.htm | EX-10.16 | 58178
3 |  | ex23-1.htm | EX-23.1 | 3523
4 |  | ex31-1.htm | EX-31.1 | 12233
5 |  | ex31-2.htm | EX-31.2 | 11870
6 |  | ex32-1.htm | EX-32.1 | 6502
7 |  | ex32-2.htm | EX-32.2 | 6494
8 |  | form10-k_001.jpg | GRAPHIC | 61474
9 |  | form10-k_002.jpg | GRAPHIC | 54212
10 |  | form10-k_003.jpg | GRAPHIC | 93931
11 |  | form10-k_004.jpg | GRAPHIC | 76215
| Complete submission text file | 0001493152-24-010427.txt |  | 9003880

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | lixt-20231231.xsd | EX-101.SCH | 48473
13 | XBRL CALCULATION FILE | lixt-20231231_cal.xml | EX-101.CAL | 41160
14 | XBRL DEFINITION FILE | lixt-20231231_def.xml | EX-101.DEF | 255068
15 | XBRL LABEL FILE | lixt-20231231_lab.xml | EX-101.LAB | 436438
16 | XBRL PRESENTATION FILE | lixt-20231231_pre.xml | EX-101.PRE | 345704
73 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1153210

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39717 | Film No.: 24761173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)